Medicure Inc.

TSXV Exchange | Jul 5, 2020, 12:47 PM EDT | Real-time price

MPH $ 1.10 RT
0.01 (0.9174%)
Day Low: 1.10
Day High: 1.10
Detailed Quote
Open: 1.10
High: 1.10
Beta: 0.5924
Shares Out.: 10,804,013
Total Shares (All Classes)2: 10,662,313
Prev. Close: 1.09
Low: 1.10
VWAP: 1.10
Escrow Shares: 0
Market Cap (All Classes)2*: 11,728,544
Dividend: N/A
Div. Frequency: N/A
P/E Ratio: N/A
Listed Shares Out.1: 10,804,013
EPS: -1.28
Yield: N/A
Ex-Div Date: N/A
P/B Ratio: 0.433
Market Cap1: 11,884,414
Exchange: TSXV

(1) Number based only on listed classes of shares.

(2) Number sourced from third party data provider. For the most up to date information, please refer to the company's financial documents.

*Market Capitalization is based on Total Shares Outstanding for all share classes for the company. Convertible bonds and employee stock options that would otherwise be included in the Diluted Shares amount included in a company's filings/financials are not included.


Medicure Inc is a specialty pharmaceutical company. It is involved in research, clinical development, and commercialization of human therapeutics for United States hospital market. Its main focus is on sale and marketing of its drug Aggrastat which is a glycoprotein GP IIb/IIIa receptor antagonist, is used for the treatment of acute coronary syndrome including unstable angina. The firm derives the majority of its revenue geographically from the United States. More

News Headlines for Medicure Inc.
Info TSX Venture

A comprehensive database of information on TSX Venture issuers

Show all links

Note: as part of an update to TMX Money, this link will be removed on June 30, 2020. Users wishing to access InfoTSXV can continue to do so directly

News Headlines for Medicure Inc.
Last 25 Trades
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. View delay times for all exchanges. Market Data powered by QuoteMedia, Fundamentals by Morningstar. See the QuoteMedia Terms of Use.